Edition:
United States

Pushkala Aripaka

EU regulator backs dexamethasone as COVID-19 treatment

Sep 18 2020

Europe's healthcare regulator has endorsed using dexamethasone to treat COVID-19 patients with breathing difficulties, paving the way for the steroid to become the region's second approved treatment for the respiratory illness.

British builders Galliford and Redrow to resume dividends

Sep 16 2020

Construction groups Galliford Try and Redrow on Wednesday pledged to resume shareholder payouts in fiscal 2021 as construction demand picked up following the lifting of coronavirus lockdowns.

WRAPUP 1-British builders Galliford and Redrow to resume dividends

Sep 16 2020

Sept 16 Construction groups Galliford Try and Redrow on Wednesday pledged to resume shareholder payouts in fiscal 2021 as construction demand picked up following the lifting of coronavirus lockdowns.

Insurer Aviva sells Singapore unit as new CEO shifts focus

Sep 11 2020

Life and general insurer Aviva is offloading its Singapore business to a consortium led by Singapore Life, for S$2.7 billion ($1.98 billion), as the London-listed firm sharpens its focus on Britain, Ireland and Canada.

Engineering group Meggitt axes dividend as profit slumps

Sep 08 2020

British engineering company Meggitt cancelled its interim dividend on Tuesday as it posted a 37% drop in first-half profit after the coronavirus crisis hit its business supplying parts to aerospace manufacturers.

CVC has no plans to launch Capita takeover bid: source

Sep 03 2020

LONDON CVC Capital Partners has no plans to launch a takeover bid for British outsourcer Capita and is only looking at specific units the company is hiving off, a source with knowledge of the matter told Reuters.

AstraZeneca bolsters COVID-19 vaccine supply with new deal

Sep 01 2020

AstraZeneca has expanded its agreement with cell therapy firm Oxford Biomedica to mass-produce its COVID-19 potential vaccine, as it looks to scale-up supply ahead of a possible U.S. fast-track approval. | Video

AstraZeneca starts trial of COVID-19 antibody treatment

Aug 25 2020

British drugmaker AstraZeneca has begun testing an antibody-based cocktail for the prevention and treatment of COVID-19, adding to recent signs of progress on possible medical solutions to the disease caused by the novel coronavirus. | Video

World News

Thousands rally in Thai capital against government

Thousands of protesters in Thailand's capital demonstrated against the government of former coup leader and Prime Minister Prayuth Chan-ocha on Saturday, with many also demanding reforms to the powerful monarchy.